Technical Analysis for RSLS - Reshape Lifesciences Inc

Grade Last Price % Change Price Change
D 2.5700 -8.21% -0.2300
RSLS closed down 8.21 percent on Friday, March 31, 2023, on 16 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -8.21%
Outside Day Range Expansion -8.21%
Wide Bands Range Expansion -8.21%
NR7 Range Contraction -12.29%
Narrow Range Bar Range Contraction -12.29%
Wide Bands Range Expansion -12.29%
Gapped Down Weakness -12.29%
Inside Day Range Contraction -17.63%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 22 hours ago
Up 1% about 22 hours ago
Down 10% 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Reshape Lifesciences Inc Description

ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Medical Specialties Clinical Medicine Anatomy Stoma Metabolic Disease Metabolic Diseases Nerve Obesity Tomy Balloon Stomach Weight Loss Laparoscopy Paros Digestive System Surgery Gastrointestinal Disorders Intestinal Disorders

Is RSLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.4
52 Week Low 0.108
Average Volume 771,509
200-Day Moving Average 2.1454
50-Day Moving Average 4.8948
20-Day Moving Average 3.1178
10-Day Moving Average 2.9485
Average True Range 0.5444
RSI 38.27
ADX 20.21
+DI 28.7727
-DI 25.7666
Chandelier Exit (Long, 3 ATRs) 2.8963
Chandelier Exit (Short, 3 ATRs) 4.1232
Upper Bollinger Bands 3.8478
Lower Bollinger Band 2.3878
Percent B (%b) 0.12
BandWidth 46.8279
MACD Line -0.5057
MACD Signal Line -0.5698
MACD Histogram 0.0641
Fundamentals Value
Market Cap 14.36 Million
Num Shares 5.59 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 2.48
Price-to-Book 1.46
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.1106
Resistance 3 (R3) 3.1473 3.0039 3.0205
Resistance 2 (R2) 3.0039 2.8662 2.9855 2.9904
Resistance 1 (R1) 2.7869 2.7811 2.7152 2.7502 2.9604
Pivot Point 2.6435 2.6435 2.6076 2.6251 2.6435
Support 1 (S1) 2.4265 2.5058 2.3548 2.3898 2.1796
Support 2 (S2) 2.2831 2.4207 2.2647 2.1496
Support 3 (S3) 2.0661 2.2831 2.1195
Support 4 (S4) 2.0294